載入...
Differences in reimbursement listing of anticancer therapies in China: an observational study
OBJECTIVE: Access to highly priced anticancer medications usually requires insurance coverage. A first step towards coverage of such medications is their inclusion in reimbursement lists. We assessed listing for reimbursement in China between 2009 and 2018 of anticancer medications on the WHO’s Esse...
Na minha lista:
| 發表在: | BMJ Open |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6955534/ https://ncbi.nlm.nih.gov/pubmed/31911513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031203 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|